AK4 could mediate adenosine 5′-monophosphate- (AMP-) activated protein kinase (AMPK) signaling and further promote the survival of glioma patients, suggesting possible effects on the progression of glioma [20]. The gene discussed is WEE1; the disease is central nervous system cancer.